JP2022552160A5 - - Google Patents

Info

Publication number
JP2022552160A5
JP2022552160A5 JP2022520608A JP2022520608A JP2022552160A5 JP 2022552160 A5 JP2022552160 A5 JP 2022552160A5 JP 2022520608 A JP2022520608 A JP 2022520608A JP 2022520608 A JP2022520608 A JP 2022520608A JP 2022552160 A5 JP2022552160 A5 JP 2022552160A5
Authority
JP
Japan
Prior art keywords
methyl
chloro
methoxy
biphenyl
phenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022520608A
Other languages
English (en)
Japanese (ja)
Other versions
JP7642625B2 (ja
JP2022552160A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/053667 external-priority patent/WO2021067521A1/en
Publication of JP2022552160A publication Critical patent/JP2022552160A/ja
Publication of JP2022552160A5 publication Critical patent/JP2022552160A5/ja
Application granted granted Critical
Publication of JP7642625B2 publication Critical patent/JP7642625B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022520608A 2019-10-04 2020-10-01 免疫調節剤として有用な化合物 Active JP7642625B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962910721P 2019-10-04 2019-10-04
US62/910,721 2019-10-04
PCT/US2020/053667 WO2021067521A1 (en) 2019-10-04 2020-10-01 Compounds useful as immunomodulators

Publications (3)

Publication Number Publication Date
JP2022552160A JP2022552160A (ja) 2022-12-15
JP2022552160A5 true JP2022552160A5 (enExample) 2023-10-10
JP7642625B2 JP7642625B2 (ja) 2025-03-10

Family

ID=73020283

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520608A Active JP7642625B2 (ja) 2019-10-04 2020-10-01 免疫調節剤として有用な化合物

Country Status (6)

Country Link
US (1) US20240124417A1 (enExample)
EP (1) EP4037776A1 (enExample)
JP (1) JP7642625B2 (enExample)
KR (1) KR20220079893A (enExample)
CN (1) CN114761085A (enExample)
WO (1) WO2021067521A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113135895A (zh) * 2021-04-30 2021-07-20 中国药科大学 一种新型联苯类衍生物及其制备方法与医药用途
KR20240004801A (ko) * 2021-05-05 2024-01-11 브리스톨-마이어스 스큅 컴퍼니 면역조절제로서 유용한 락톤 및 락탐 함유 화합물
CN116730940B (zh) * 2023-06-13 2024-08-30 中国药科大学 杂环取代联苯类化合物及其医药用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410690B1 (en) 1995-06-07 2002-06-25 Medarex, Inc. Therapeutic compounds comprised of anti-Fc receptor antibodies
US5811097A (en) 1995-07-25 1998-09-22 The Regents Of The University Of California Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
US5922845A (en) 1996-07-11 1999-07-13 Medarex, Inc. Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
CN105705489B (zh) * 2013-09-04 2019-04-26 百时美施贵宝公司 用作免疫调节剂的化合物
US9850225B2 (en) * 2014-04-14 2017-12-26 Bristol-Myers Squibb Company Compounds useful as immunomodulators
US10745382B2 (en) * 2015-10-15 2020-08-18 Bristol-Myers Squibb Company Compounds useful as immunomodulators
US10144706B2 (en) * 2016-09-01 2018-12-04 Bristol-Myers Squibb Company Compounds useful as immunomodulators
CN111788193B (zh) * 2018-03-13 2023-04-04 广东东阳光药业有限公司 Pd-1/pd-l1类小分子抑制剂及其在药物中的应用
US12083118B2 (en) * 2018-03-29 2024-09-10 Arbutus Biopharma Corporation Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same

Similar Documents

Publication Publication Date Title
JP2013523884A5 (enExample)
US10301280B2 (en) Compounds and methods for kinase modulation, and indications therefor
CA2900855C (en) Aminopyrimidinyl compounds
ES2346674T3 (es) Compuestos heteroaromaticos de quinolina y su uso como inhibidores de pde10.
JP2022552160A5 (enExample)
CA2703125A1 (en) Pyrazinyl-substituted pyrrolo[2,3-b]pyridines, compositions thereof, and their use in the treatment of cancer
JP2021502356A5 (enExample)
RU2014118954A (ru) 5,7-ЗАМЕЩЕННЫЕ-ИМИДАЗО[1,2-c]ПИРИМИДИНЫ
JP2018522046A5 (enExample)
RU2012131124A (ru) Птеридиноны как ингибиторы polo-подобных киназ
RU2014139601A (ru) Ингибиторы серин/треониновых киназ
RU2016140338A (ru) Азаспиро производные в качестве антагонистов trpm8
JP2014531465A5 (enExample)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
HRP20180546T1 (hr) Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti
JP2017528519A5 (enExample)
RU2015129538A (ru) Замещенные имидазопиридины в качестве ингибиторов hdm2
JP2007523182A5 (enExample)
JP2018530591A5 (enExample)
RU2014154397A (ru) Соединения тетрагидропиразолопиримидина
RU2012136643A (ru) [5,6]- гетероциклическое соединение
JP2011500806A5 (enExample)
RU2013155456A (ru) Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka
HRP20160539T1 (hr) Antagonisti trpv4
JP2021523177A5 (enExample)